• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白藜芦醇四聚体(-)-hopeaphenol 抑制革兰氏阴性病原体耶尔森氏菌和铜绿假单胞菌的 III 型分泌。

The resveratrol tetramer (-)-hopeaphenol inhibits type III secretion in the gram-negative pathogens Yersinia pseudotuberculosis and Pseudomonas aeruginosa.

机构信息

Umeå Centre for Microbial Research, Laboratories for Infection Medicine Sweden, Department of Chemistry, Umeå University, Umeå, Sweden.

出版信息

PLoS One. 2013 Dec 4;8(12):e81969. doi: 10.1371/journal.pone.0081969. eCollection 2013.

DOI:10.1371/journal.pone.0081969
PMID:24324737
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3853165/
Abstract

Society faces huge challenges, as a large number of bacteria have developed resistance towards many or all of the antibiotics currently available. Novel strategies that can help solve this problem are urgently needed. One such strategy is to target bacterial virulence, the ability to cause disease e.g., by inhibition of type III secretion systems (T3SSs) utilized by many clinically relevant gram-negative pathogens. Many of the antibiotics used today originate from natural sources. In contrast, most virulence-blocking compounds towards the T3SS identified so far are small organic molecules. A recent high-throughput screening of a prefractionated natural product library identified the resveratrol tetramer (-)-hopeaphenol as an inhibitor of the T3SS in Yersinia pseudotuberculosis. In this study we have investigated the virulence blocking properties of (-)-hopeaphenol in three different gram-negative bacteria. (-)-Hopeaphenol was found to have micromolar activity towards the T3SSs in Yersinia pseudotuberculosis and Pseudomonas aeruginosa in cell-based infection models. In addition (-)-hopeaphenol reduced cell entry and subsequent intracellular growth of Chlamydia trachomatis.

摘要

社会面临着巨大的挑战,因为大量细菌对目前可用的许多或所有抗生素都产生了耐药性。急需寻找新的策略来解决这个问题。一种这样的策略是针对细菌的毒力,即引起疾病的能力,例如通过抑制许多临床相关的革兰氏阴性病原体利用的 III 型分泌系统(T3SS)。目前使用的许多抗生素都来源于天然来源。相比之下,迄今为止发现的针对 T3SS 的大多数毒力阻断化合物都是小分子有机化合物。最近对预分级天然产物文库进行高通量筛选,鉴定出白藜芦醇四聚体(-)-白藜芦醇酚是假结核耶尔森氏菌 T3SS 的抑制剂。在这项研究中,我们研究了(-)-白藜芦醇酚在三种不同的革兰氏阴性菌中的毒力阻断特性。在基于细胞的感染模型中,(-)-白藜芦醇酚对假结核耶尔森氏菌和铜绿假单胞菌的 T3SS 具有微摩尔活性。此外,(-)-白藜芦醇酚还减少了沙眼衣原体的细胞进入和随后的细胞内生长。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9302/3853165/2a2b1f5c8aac/pone.0081969.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9302/3853165/420104d17e33/pone.0081969.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9302/3853165/d554e5c533f5/pone.0081969.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9302/3853165/063bcc55268c/pone.0081969.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9302/3853165/84261d441d2b/pone.0081969.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9302/3853165/42293dead84c/pone.0081969.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9302/3853165/a1ccb9fb79e9/pone.0081969.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9302/3853165/4cab05821841/pone.0081969.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9302/3853165/ca4e90f6979a/pone.0081969.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9302/3853165/cd711cca5f58/pone.0081969.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9302/3853165/2a2b1f5c8aac/pone.0081969.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9302/3853165/420104d17e33/pone.0081969.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9302/3853165/d554e5c533f5/pone.0081969.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9302/3853165/063bcc55268c/pone.0081969.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9302/3853165/84261d441d2b/pone.0081969.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9302/3853165/42293dead84c/pone.0081969.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9302/3853165/a1ccb9fb79e9/pone.0081969.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9302/3853165/4cab05821841/pone.0081969.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9302/3853165/ca4e90f6979a/pone.0081969.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9302/3853165/cd711cca5f58/pone.0081969.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9302/3853165/2a2b1f5c8aac/pone.0081969.g010.jpg

相似文献

1
The resveratrol tetramer (-)-hopeaphenol inhibits type III secretion in the gram-negative pathogens Yersinia pseudotuberculosis and Pseudomonas aeruginosa.白藜芦醇四聚体(-)-hopeaphenol 抑制革兰氏阴性病原体耶尔森氏菌和铜绿假单胞菌的 III 型分泌。
PLoS One. 2013 Dec 4;8(12):e81969. doi: 10.1371/journal.pone.0081969. eCollection 2013.
2
Exploring resveratrol dimers as virulence blocking agents - Attenuation of type III secretion in Yersinia pseudotuberculosis and Pseudomonas aeruginosa.探索白藜芦醇二聚体作为毒力阻断剂 - 减弱假结核耶尔森氏菌和铜绿假单胞菌的 III 型分泌系统。
Sci Rep. 2020 Feb 7;10(1):2103. doi: 10.1038/s41598-020-58872-0.
3
Synthetic Cyclic Peptomers as Type III Secretion System Inhibitors.合成环肽类作为 III 型分泌系统抑制剂。
Antimicrob Agents Chemother. 2017 Aug 24;61(9). doi: 10.1128/AAC.00060-17. Print 2017 Sep.
4
Developing Cyclic Peptomers as Broad-Spectrum Type III Secretion System Inhibitors in Gram-Negative Bacteria.开发环状缩肽作为革兰氏阴性菌中广谱 III 型分泌系统抑制剂。
Antimicrob Agents Chemother. 2021 Jun 17;65(7):e0169020. doi: 10.1128/AAC.01690-20.
5
An NF-κB-based high-throughput screen identifies piericidins as inhibitors of the Yersinia pseudotuberculosis type III secretion system.一种基于 NF-κB 的高通量筛选方法鉴定出皮里菌素是耶尔森氏菌Ⅲ型分泌系统的抑制剂。
Antimicrob Agents Chemother. 2014;58(2):1118-26. doi: 10.1128/AAC.02025-13. Epub 2013 Dec 2.
6
Solving the supply of resveratrol tetramers from Papua New Guinean rainforest anisoptera species that inhibit bacterial type III secretion systems.从巴布亚新几内亚雨林的 anisoptera 物种中提取抑制细菌 III 型分泌系统的白藜芦醇四聚体,以解决其供应问题。
J Nat Prod. 2014 Dec 26;77(12):2633-40. doi: 10.1021/np500433z. Epub 2014 Nov 18.
7
A type III secretion system inhibitor targets YopD while revealing differential regulation of secretion in calcium-blind mutants of Yersinia pestis.一种 III 型分泌系统抑制剂靶向 YopD 的同时,揭示了鼠疫耶尔森氏菌钙敏感受体突变体中分泌的差异调控。
Antimicrob Agents Chemother. 2014;58(2):839-50. doi: 10.1128/AAC.01170-13. Epub 2013 Nov 18.
8
An Experimental Pipeline for Initial Characterization of Bacterial Type III Secretion System Inhibitor Mode of Action Using Enteropathogenic .利用肠致病性. 初步表征细菌 III 型分泌系统抑制剂作用模式的实验流程
Front Cell Infect Microbiol. 2018 Nov 22;8:404. doi: 10.3389/fcimb.2018.00404. eCollection 2018.
9
YopN Is Required for Efficient Effector Translocation and Virulence in Yersinia pseudotuberculosis.YopN 对于假结核耶尔森氏菌的有效效应子易位和毒力是必需的。
Infect Immun. 2018 Jul 23;86(8). doi: 10.1128/IAI.00957-17. Print 2018 Aug.
10
Statistical molecular design of a focused salicylidene acylhydrazide library and multivariate QSAR of inhibition of type III secretion in the Gram-negative bacterium Yersinia.基于统计的水杨醛酰腙类化合物库的靶向设计及革兰氏阴性菌耶尔森氏菌 III 型分泌系统抑制的多元定量构效关系研究
Bioorg Med Chem. 2010 Apr 1;18(7):2686-703. doi: 10.1016/j.bmc.2010.02.022. Epub 2010 Feb 18.

引用本文的文献

1
Emerging Trends in Green Extraction Techniques, Chemical Modifications, and Drug Delivery Systems for Resveratrol.白藜芦醇绿色提取技术、化学修饰及药物递送系统的新趋势
Antioxidants (Basel). 2025 May 29;14(6):654. doi: 10.3390/antiox14060654.
2
Progress of Antimicrobial Mechanisms of Stilbenoids.芪类化合物抗菌机制的研究进展
Pharmaceutics. 2024 May 15;16(5):663. doi: 10.3390/pharmaceutics16050663.
3
Using next generation antimicrobials to target the mechanisms of infection.使用新一代抗菌药物来针对感染机制。

本文引用的文献

1
Small molecules aimed at type III secretion systems to inhibit bacterial virulence.针对III型分泌系统以抑制细菌毒力的小分子。
Medchemcomm. 2013 Jan 1;4(1):68-79. doi: 10.1039/C2MD20213A.
2
Small-molecule inhibitors suppress the expression of both type III secretion and amylovoran biosynthesis genes in Erwinia amylovora.小分子抑制剂抑制了果胶黏性类细菌Ⅲ型分泌系统和果胶聚糖合成基因的表达。
Mol Plant Pathol. 2014 Jan;15(1):44-57. doi: 10.1111/mpp.12064. Epub 2013 Aug 5.
3
Chemical inhibitors of the type three secretion system: disarming bacterial pathogens.
NPJ Antimicrob Resist. 2023;1(1):11. doi: 10.1038/s44259-023-00011-6. Epub 2023 Sep 22.
4
Recent advances in the discovery of plant-derived antimicrobial natural products to combat antimicrobial resistant pathogens: insights from 2018-2022.近年来发现的植物源抗菌天然产物在对抗抗微生物药物耐药性病原体方面的进展:2018-2022 年的研究进展。
Nat Prod Rep. 2023 Jul 19;40(7):1271-1290. doi: 10.1039/d2np00090c.
5
Type III Secretion in .III 型分泌系统在... 中。
Microbiol Mol Biol Rev. 2023 Sep 26;87(3):e0003423. doi: 10.1128/mmbr.00034-23. Epub 2023 Jun 26.
6
High-Throughput Screening of Natural Product and Synthetic Molecule Libraries for Antibacterial Drug Discovery.用于抗菌药物发现的天然产物和合成分子文库的高通量筛选
Metabolites. 2023 May 2;13(5):625. doi: 10.3390/metabo13050625.
7
The Natural Stilbenoid (-)-Hopeaphenol Inhibits HIV Transcription by Targeting Both PKC and NF-κB Signaling and Cyclin-Dependent Kinase 9.(-)-原花青素抑制 HIV 转录的作用机制研究——靶向 PKC 和 NF-κB 信号通路以及细胞周期蛋白依赖性激酶 9
Antimicrob Agents Chemother. 2023 Apr 18;67(4):e0160022. doi: 10.1128/aac.01600-22. Epub 2023 Mar 15.
8
Targeting bacterial pathogenesis by inhibiting virulence-associated Type III and Type IV secretion systems.通过抑制与毒力相关的 III 型和 IV 型分泌系统来靶向细菌发病机制。
Front Cell Infect Microbiol. 2023 Jan 10;12:1065561. doi: 10.3389/fcimb.2022.1065561. eCollection 2022.
9
Research Progress on Small Molecular Inhibitors of the Type 3 Secretion System.III 型分泌系统小分子抑制剂的研究进展。
Molecules. 2022 Nov 30;27(23):8348. doi: 10.3390/molecules27238348.
10
Pseudomonas aeruginosa Antivirulence Strategies: Targeting the Type III Secretion System.铜绿假单胞菌抗毒力策略:靶向 III 型分泌系统。
Adv Exp Med Biol. 2022;1386:257-280. doi: 10.1007/978-3-031-08491-1_9.
三类分泌系统的化学抑制剂:瓦解细菌病原体。
Antimicrob Agents Chemother. 2012 Nov;56(11):5433-41. doi: 10.1128/AAC.00975-12. Epub 2012 Jul 30.
4
In vitro anti-HIV-1 activity of salicylidene acylhydrazide compounds.水杨醛酰腙类化合物的体外抗 HIV-1 活性。
Int J Antimicrob Agents. 2012 Oct;40(4):354-60. doi: 10.1016/j.ijantimicag.2012.05.023. Epub 2012 Jul 20.
5
Preliminary pharmacokinetics of the bacterial virulence inhibitor n'-(3,5-dibromo-2-hydroxy-benzylidenene)-nicotinic Acid hydrazide.细菌毒力抑制剂N'-(3,5-二溴-2-羟基-亚苄基)-烟酰肼的初步药代动力学
Adv Exp Med Biol. 2012;954:349-56. doi: 10.1007/978-1-4614-3561-7_42.
6
Derivatives of 8-hydroxyquinoline--antibacterial agents that target intra- and extracellular Gram-negative pathogens.8-羟基喹啉衍生物——针对细胞内和细胞外革兰氏阴性病原体的抗菌剂。
Bioorg Med Chem Lett. 2012 May 15;22(10):3550-3. doi: 10.1016/j.bmcl.2012.03.096. Epub 2012 Apr 6.
7
The type III secretion system as a source of novel antibacterial drug targets.III 型分泌系统作为新型抗菌药物靶点的来源。
Curr Drug Targets. 2012 Mar;13(3):338-51. doi: 10.2174/138945012799424642.
8
Drug-like properties: guiding principles for the design of natural product libraries.类药性:天然产物库设计的指导原则。
J Nat Prod. 2012 Jan 27;75(1):72-81. doi: 10.1021/np200687v. Epub 2011 Dec 28.
9
Syntheses of pseudoceramines A-D and a new synthesis of spermatinamine, bromotyrosine natural products from marine sponges.伪角硅烷 A-D 的合成及海绵来源溴酪氨酸天然产物精子胺的新合成。
Org Biomol Chem. 2012 Feb 14;10(6):1246-54. doi: 10.1039/c1ob06722b. Epub 2011 Dec 19.
10
Derivatives of plant phenolic compound affect the type III secretion system of Pseudomonas aeruginosa via a GacS-GacA two-component signal transduction system.植物酚类化合物衍生物通过 GacS-GacA 双组分信号转导系统影响铜绿假单胞菌的 III 型分泌系统。
Antimicrob Agents Chemother. 2012 Jan;56(1):36-43. doi: 10.1128/AAC.00732-11. Epub 2011 Oct 3.